Worksport is developing and preparing to commercialize its COR™ and SOLIS™ products, which the company highlights as core to its growth strategy. The firm intends to use newly raised capital to accelerate product launches and broader growth initiatives. Management states that the fresh funding eliminates near-term capital uncertainty. In addition, Worksport has embedded $4.50 warrants in the raise, potentially supplying additional, success-based capital in the future. The company is targeting cash-flow positivity by early 2026. Overall, Worksport’s current financial strategy is centered on leveraging the recent raise to fund commercialization, drive revenue growth, and reach profitability within the next fifteen months.

Total raised

$10M

Funding rounds

1

Latest round

Equity

Latest activity

Oct 2025